11C-Acetate PET imaging in patients with multiple sclerosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Takata, Kazushiro ^a   Kato, Hiroki ^a   Shimosegawa, Eku ^a   Okuno, Tatsusada ^a   Koda, Toru ^a   Sugimoto, Tomoyuki ^b   Mochizuki, Hideki ^a   Hatazawa, Jun ^a,c   Nakatsuji, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; BETA INTERFERON; ACETIC ACID; CARBON;

ADULT; ARTICLE; ASTROCYTE; CELL ACTIVITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER; AGED; BRAIN; DIAGNOSTIC USE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; PROCEDURES;

ACETIC ACID; ADULT; AGED; BRAIN; CARBON RADIOISOTOPES; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84928309712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111598     Document Type: Article

References (40)

1. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359: 1221-1231.
2. Sormani MP, Bruzzi P (2013) MRI lesions as a surrogate for relapses in multiple sclerosis: A meta-analysis of randomised trials. Lancet Neurol 12: 669-676.
3. Odenthal A, Coulthard C (2014) The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review. AJNR Am J Neuroradiol.
4. Fernando KT, McLean MA, Chard DT, MacManus DG, Dalton CM, et al. (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127: 1361-1369.
5. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (Pt 11): 2321-2337.
6. Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, et al. (2012) Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 79: 523-530.
7. Black JA, Newcombe J, Waxman SG (2010) Astro cytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. Brain 133: 835-846.
8. Brosnan CF, Raine CS (2013) The astrocyte in multiple sclerosis revisited. Glia 61: 453-465.
9. Brown M, Marshall DR, Sobel BE, Bergmann SR (1987) Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 76: 687-696.
10. Oyama N, Okazawa H, Kusukawa N, Kaneda T, Miwa Y, et al. (2009) 11CAcetate PET imaging for renal cell carcinoma. Eur J Nucl Med Mol Imaging 36: 422-427.
11. Ho CL, Yu SC, Yeung DW (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44: 213-221.
12. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, et al. (2002) 11Cacetate PET imaging of prostate cancer. J Nucl Med 43: 181-186.
13. Lin C, Ho CL, Ng SH, Wang PN, Huang Y, et al. (2014) (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: Initial staging and postinduction response assessment. Eur J Nucl Med Mol Imaging 41: 41-49.
14. Liu RS, Chang CP, Chu LS, Chu YK, Hsieh HJ, et al. (2006) PET imaging of brain astrocytoma with 1-11C-acetate. Eur J Nucl Med Mol Imaging 33: 420- 427.
15. Waniewski RA, Martin DL (1998) Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18: 5225-5233.
16. Hosoi R, Okada M, Hatazawa J, Gee A, Inoue O (2004) Effect of astrocytic energy metabolism depressant on 14C-acetate uptake in intact rat brain. J Cereb Blood Flow Metab 24: 188-190.
17. Nijland PG, Michailidou I, Witte ME, Mizee MR, van der Pol SM, et al. (2014) Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions. Glia 62: 1125-1141.
18. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444-1452.
19. Ishiwata K, Ishii S-I, Senda M (1995) Successive preparation of 11C labeled sodium acetate and/or sodium hexanoate. Applied Radiation and Isotopes 46: 1035-1037.
20. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26: 839-851.
21. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, et al. (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21-36.
22. Hosoi R, Matsuyama Y, Hirose S, Koyama Y, Matsuda T, et al. (2009) Characterization of (14)C-acetate uptake in cultured rat astrocytes. Brain Res 1253: 69-73.
23. Kato H, Shimosegawa E, Isohashi K, Kimura N, Kazui H, et al. (2012) Distribution of cortical benzodiazepine receptor binding in right-handed healthy humans: A voxel-based statistical analysis of iodine 123 iomazenil SPECT with partial volume correction. AJNR Am J Neuroradiol 33: 1458-1463.
24. Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25: 315-320.
25. Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, et al. (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 125: 2342-2352.
26. Srivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, et al. (2012) Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 367: 115-123.
27. Wyss MT, Weber B, Treyer V, Heer S, Pellerin L, et al. (2009) Stimulationinduced increases of astrocytic oxidative metabolism in rats and humans investigated with 1-11C-acetate. J Cereb Blood Flow Metab 29: 44-56.
28. De Keyser J, Steen C, Mostert JP, Koch MW (2008) Hypoperfusion of the cerebral white matter in multiple sclerosis: Possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 28: 1645-1651.
29. Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, et al. (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132: 239-249.
30. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57: 1248-1252.
31. Sharma R, Fischer MT, Bauer J, Felts PA, Smith KJ, et al. (2010) Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 120: 223- 236.
32. Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, et al. (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A 108: 751-756.
33. Naismith RT, Xu J, Tutlam NT, Scully PT, Trinkaus K, et al. (2010) Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 74: 1694-1701.
34. Sahraian MA, Radue EW, Haller S, Kappos L (2010) Black holes in multiple sclerosis: Definition, evolution, and clinical correlations. Acta Neurol Scand 122: 1-8.
35. Blinkenberg M, Rune K, Jensen CV, Ravnborg M, Kyllingsbaek S, et al. (2000) Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 54: 558-564.
36. Vercellino M, Merola A, Piacentino C, Votta B, Capello E, et al. (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66: 732-739.
37. Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, et al. (2006) Neuronalglial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab 26: 865-877.
38. Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, et al. (2005) Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51: 235-240.
39. Van den Berg CJ, Mela P, Waelsch H (1966) On the contribution of the tricarboxylic acid cycle to the synthesis of glutamate, glutamine and aspartate in brain. Biochem Biophys Res Commun 23: 479-484.
40. Wyss MT, Magistretti PJ, Buck A, Weber B (2011) Labeled acetate as a marker of astrocytic metabolism. J Cereb Blood Flow Metab 31: 1668-1674.